Abiopharma

High Roller Technologies Launches Beta Version of ROLR™ Prediction Markets Platform; Commercial Launch on Track for October 2026

Aardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadline

UWMC INVESTOR ALERT: UWM Holdings Corporation Investors with $150K+ Losses Have Opportunity to Lead UWM Class Action Lawsuit

AnalogAI Selects memBrain™ SAGE Intellectual Property from Silicon Storage Technology® for its First Real-world Edge AI Processors

(99% Neutral) CORTEVA, INC. (CTVA) Announces Business Combination

HDB ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages HDFC Bank Limited (NYSE: HDB) Investors to Contact its Legal Team Regarding Securities Fraud Class Action Lawsuit

Net Asset Value(s)

DNOW Inc. (DNOW) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 2, 2026 Lead Plaintiff Deadline

NKGen Biotech to Present on Troculeucel for Neurodegenerative Diseases at 4th Great Bay Cell and Gene Therapy Forum

(99% Neutral) RB GLOBAL INC. (RBA) Announces Business Combination

Share Buy Back - Daily Share Buy-Back Notice: Daily Share Buy-Back Notice

(19% Negative) LB PHARMACEUTICALS INC (LBRX) Announces Delay in trial Development Timeline Due to Regulatory Process, Manufacturing Considerations, Safety Review

Agilysys to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference

NKGen Biotech to Present on Troculeucel for Neurodegenerative Diseases at 4th Great Bay Cell and Gene Therapy Forum

Pentair plc (PNR) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 2, 2026 Lead Plaintiff Deadline